Autoantibodies to the extracellular matrix microfibrillar protein, fibrillin-1, in patients with scleroderma and other connective tissue diseases.

A duplication in the fibrillin-1 gene has been implicated as the cause of the tight skin 1 (tsk1) phenotype, an animal model of scleroderma or systemic sclerosis (SSc). In addition to the production of abnormal fibrillin-1 protein, the tsk1 mouse also produces autoantibodies to fibrillin-1. Among a population of Choctaw Native Americans with the highest prevalence of SSc yet described, a chromosome 15q haplotype containing the fibrillin-1 gene has been strongly associated with SSc. With a recombinant human fibrillin-1 protein, autoantibodies to fibrillin-1 were detected in the sera of Native American SSc patients that correlated significantly with disease. Abs to fibrillin-1 also were detected in sera from Japanese, Caucasian, and African-American SSc patients. Compared with other ethnic groups, Japanese and Native American SSc patients had significantly higher frequencies of anti-fibrillin-1 Abs. Sera from patients with diffuse SSc, calcinosis, Raynaud's, esophageal dysmotility, sclerodactyly, and telangiectasias syndrome and mixed connective tissue disease also had significantly higher frequencies of anti-fibrillin-1 Abs than sera from controls or patients with other non-SSc connective tissue diseases (lupus, rheumatoid arthritis, and Sjögren's syndrome). Ab specificity for fibrillin-1 was demonstrated by the lack of binding to a panel of other purified autoantigens. The results presented demonstrate for the first time the presence of high levels of anti-fibrillin-1 Abs in a significant portion of patients with SSc.

• Publication year

  1999

• Venue

  Journal of Immunology

• Publication date

  1999-07-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.4049/jimmunol.163.2.1066PMID 10395706
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Polymyositis and dermatomyositis

  2002cited by this paper
• Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody.

  1999cited by this paper
• Characterization of mutated protein encoded by partially duplicated fibrillin-1 gene in tight skin (TSK) mice.

  1999cited by this paper
• The Tight Skin Mouse: Demonstration of Mutant Fibrillin-1 Production and Assembly into Abnormal Microfibrils

  1998cited by this paper
• Association of microsatellite markers near the fibrillin 1 gene on human chromosome 15q with scleroderma in a Native American population.

  1998cited by this paper
• Spontaneous occurrence of anti-fibrillin-1 autoantibodies in tight-skin mice.

  1998cited by this paper
• B-cell deficiency does not abrogate development of cutaneous hyperplasia in mice inheriting the defective fibrillin-1 gene.

  1997cited by this paper
• Fibrillin-1: organization in microfibrils and structural properties.

  1996cited by this paper
• Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype.

  1996cited by this paper
• A tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation.

  1996cited by this paper
• Antifibrillarin autoantibodies present in systemic sclerosis and other connective tissue diseases interact with similar epitopes

  1995cited by this paper
• T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors.

  1995cited by this paper
• Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders.

  1995cited by this paper
• HLA and autoimmunity in scleroderma (systemic sclerosis).

  1995cited by this paper
• Primary Structure and Developmental Expression of Fbn-1, the Mouse Fibrillin Gene (*)

  1995cited by this paper
• Structure and expression of fibrillin-2, a novel microfibrillar component preferentially located in elastic matrices

  1994cited by this paper
• Autoantibodies in scleroderma and tightskin mice.

  1994cited by this paper
• Molecular genetics of systemic sclerosis

  1993cited by this paper
• The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma).

  1993cited by this paper
• Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis).

  1992cited by this paper
• Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma).

  1992cited by this paper
• The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

  1988cited by this paper
• The 1982 revised criteria for the classification of systemic lupus erythematosus.

  1982cited by this paper
• D-Penicillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysis.

  1982cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma).

  1980cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

  1980cited by this paper
• Tight-skin, a new mutation of the mouse causing excessive growth of connective tissue and skeleton.

  1976cited by this paper
• Polymyositis and dermatomyositis (first of two parts).

  1975cited by this paper
• Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA).

  1972cited by this paper
• ARTHRITIS AND ALLIED CONDITIONS

  1949cited by this paper

• Marfan Syndrome and Related Disorders

  2025cites this paper
• Impaired bone morphogenetic protein (BMP) signaling pathways disrupt decidualization in endometriosis

  2024cites this paper
• Single-Cell Transcriptome Analysis Identifies Subclusters with Inflammatory Fibroblast Responses in Localized Scleroderma

  2023cites this paper
• Biomarkers in the Pathogenesis, Diagnosis, and Treatment of Systemic Sclerosis

  2023cites this paper
• Kidney transplantation in systemic sclerosis: Advances in graft, disease, and patient outcome

  2022cites this paper
• Mass spectrometry-based proteomics identify novel serum osteoarthritis biomarkers

  2022cites this paper
• Can Antinuclear Antibodies Have a Pathogenic Role in Systemic Sclerosis?

  2022cites this paper
• Amino acid sequence homology between thyroid autoantigens and central nervous system proteins: Implications for the steroid-responsive encephalopathy associated with autoimmune thyroiditis

  2021cites this paper
• Putative functional pathogenic autoantibodies in systemic sclerosis.

  2020cites this paper
• Systemic sclerosis (scleroderma)

  2020cites this paper
• Pathogenic Roles of Autoantibodies and Aberrant Epigenetic Regulation of Immune and Connective Tissue Cells in the Tissue Fibrosis of Patients with Systemic Sclerosis

  2020cites this paper
• Pathogenic roles of autoantibodies in systemic sclerosis: Current understandings in pathogenesis

  2019cites this paper
• Oral Signs of Connective Tissue Disease

  2019cites this paper
• Assessing the response of morphea and limited scleroderma to tranilast: a small prospective study comparing topical corticosteroids to a combination of topical corticosteroids and tranilast

  2018cites this paper
• Dissecting the enigma of scleroderma: possible involvement of the kynurenine pathway

  2017cites this paper
• Minimally important differences and risk levels for the Composite Asthma Severity Index.

  2017cites this paper
• Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities

  2017cites this paper
• Role of B cells in the pathogenesis of systemic sclerosis.

  2017cites this paper
• The Clinical Aspects of Autoantibodies

  2017cites this paper
• B cells differentiate in human thymus and express AIRE.

  2017cites this paper
• Autoantibodies as Markers and Possible Mediators of Scleroderma Pathogenesis

  2017cites this paper
• Current perspectives on the immunopathogenesis of systemic sclerosis

  2016cites this paper
• Autoantibodies and Their Role in Scleroderma Clinical Care

  2016cites this paper
• Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide

  2015cites this paper
• Thérapie ciblée anti-OX40 Ligand dans des modèles murins de Sclérodermie systémique

  2015cites this paper
• The Aryl Hydrocarbon Receptor: A Review of Its Role in the Physiology and Pathology of the Integument and Its Relationship to the Tryptophan Metabolism

  2015cites this paper
• FACULTE DE MEDECINE ET DE PHARMACIE DE ROUEN

  2015cites this paper
• Molecular and cellular basis of scleroderma

  2014cites this paper
• B-Cell Targeted Therapies in Systemic Sclerosis and Inflammatory Myopathies

  2014cites this paper
• Animal models of systemic sclerosis: their utility and limitations

  2014cites this paper
• Systemic Sclerosis Immunoglobulin Induces Growth and a Pro-Fibrotic State in Vascular Smooth Muscle Cells through the Epidermal Growth Factor Receptor

  2014cites this paper
• Autoantibodies in systemic sclerosis.

  2013influential citation
• Systemic sclerosis sera affect fibrillin-1 deposition by dermal blood microvascular endothelial cells: therapeutic implications of cyclophosphamide

  2013cites this paper
• Transplantation rénale dans le cadre de la sclérodermie systémique : étude française multicentrique

  2013cites this paper
• Recommendations of the Brazilian Society of Rheumatology Recommendations for the management and treatment of systemic sclerosis

  2013cites this paper
• Recomendações sobre diagnóstico e tratamento da esclerose sistêmica

  2013cites this paper
• Clinical Presentation and Evaluation of Dermatomyositis

  2012cites this paper
• Endothelin receptor antagonists: effects on extracellular matrix synthesis in primary cultures of skin fibroblasts from systemic sclerosis patients.

  2012cites this paper
• Idiopathic connective tissue disorders

  2012cites this paper
• Autoantibodies in Pathogenesis

  2012cites this paper
• Anti-fi brillin-1 autoantibodies in normal pregnancy and recurrent pregnancy loss

  2011cites this paper
• Alteration of fibroblast phenotype by asbestos-induced autoantibodies

  2011cites this paper
• Pathogenesis of systemic sclerosis

  2011cites this paper
• Caractérisation de l'interaction de l'auto-antigène ADN topoisomérase I avec les fibroblastes dans la sclérose systémique

  2011cites this paper
• Anti-fibrillin-1 autoantibodies in normal pregnancy and recurrent pregnancy loss.

  2011cites this paper
• Fibrosis and immune dysregulation in systemic sclerosis.

  2011cites this paper
• Secondary pulmonary hypertension

  2010cites this paper
• Mutations in Fibrillin-1 Cause Congenital Scleroderma: Stiff Skin Syndrome

  2010influential citation
• Dermal tissue and cellular expression of fibrillin-1 in diffuse cutaneous systemic sclerosis.

  2010cites this paper
• [Interactions between fibrillin-1 and tgf-beta: consequences and human pathology].

  2009cites this paper
• Interactions entre la Fibrilline-1 et le TGF-β - Conséquences en pathologie humaine

  2009cites this paper
• Animal Models of Scleroderma: From Cellular and Molecular Mechanisms to Novel Antifibrotic Strategies

  2009cites this paper
• IgG from patients with systemic sclerosis bind to DNA antitopoisomerase 1 in normal human fibroblasts extracts

  2008cites this paper
• Fibrillin‐1 in incisional hernias: an immunohistochemical study in scar and non‐scar regions of human skin and muscle fasciae

  2008cites this paper
• B‐lymphocyte contributions to human autoimmune disease

  2008cites this paper
• Marfan syndrome and related disorders.

  2008cites this paper
• Blockade of CD40–CD40 Ligand Interactions Attenuates Skin Fibrosis and Autoimmunity in the Tight-skin Mouse

  2007cites this paper
• Recent Advances on Pathogenesis and Therapies in Systemic Sclerosis

  2007cites this paper
• Blockade of CD40/CD40 ligand interactions attenuates skin fibrosis and autoimmunity in the tight-skin mouse

  2007cites this paper
• Autoimmunity in systemic sclerosis: Current concepts

  2007cites this paper
• BAFF antagonist attenuates the development of skin fibrosis in tight-skin mice.

  2007cites this paper
• Update on autoantibodies in systemic sclerosis

  2007cites this paper
• Update on pathophysiology of scleroderma with special reference to immunoinflammatory events

  2007cites this paper
• Autoantibodies in systemic sclerosis (scleroderma): clues for clinical evaluation, prognosis and pathogenesis

  2007cites this paper
• Pathogenic autoantibodies in systemic sclerosis.

  2007cites this paper
• Fibulin‐5 is involved in phlebosclerosis of major portal vein branches associated with elastic fiber deposition in idiopathic portal hypertension

  2007cites this paper
• Therapeutic transforming growth factor-β blockade in systemic sclerosis

  2006cites this paper
• Sclerotic skin disease: when smooth skin is unwelcome

  2006cites this paper
• [Scleroderma associated autoantibodies - clinical and diagnostic relevance].

  2006cites this paper
• B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis.

  2006cites this paper
• Dermatologists can participate in the holistic care of patients by aiding in early diagnosis and contributing to the management of specific cutaneous complications.

  2006cites this paper
• Hepatocyte growth factor ameliorates dermal sclerosis in the tight-skin mouse model of scleroderma

  2006cites this paper
• Characterisation of the immune response to type I collagen in scleroderma

  2006cites this paper
• Anti-endothelial cell antibodies from patients with limited cutaneous systemic sclerosis bind to centromeric protein B (CENP-B).

  2006cites this paper
• Sklerodermie-assoziierte Autoantikörper – klinische und diagnostische Relevanz

  2006cites this paper
• Fibrillins: from biogenesis of microfibrils to signaling functions.

  2006cites this paper
• Induction of apoptosis and fibrillin 1 expression in human dermal endothelial cells by scleroderma sera containing anti-endothelial cell antibodies.

  2006cites this paper
• Mixed connective tissue disease: still crazy after all these years.

  2005cites this paper
• Autoantibodies to Fibrillin-1 Activate Normal Human Fibroblasts in Culture through the TGF-β Pathway to Recapitulate the “Scleroderma Phenotype”1

  2005cites this paper
• Analysis of the tight skin (Tsk1/+) mouse as a model for testing antifibrotic agents

  2005cites this paper
• Rheumatic diseases in minority populations.

  2005cites this paper
• Localized scleroderma is an autoimmune disorder.

  2005cites this paper
• Absence of autoantibodies against correctly folded recombinant fibrillin-1 protein in systemic sclerosis patients

  2005influential citation
• Damage and inflammation in muscular dystrophy: potential implications and relationships with autoimmune myositis

  2005cites this paper
• B lymphocytes and systemic sclerosis

  2005cites this paper
• Serum fibrillin-antifibrillin immune complexes among diabetic children.

  2005cites this paper
• MCTD – Mixed Connective Tissue Disease

  2005cites this paper
• Raynaud's phenomenon in mixed connective tissue disease.

  2005cites this paper
• The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system.

  2005cites this paper
• 7 Mixed Connective Tissue Disease

  2005cites this paper
• ''Scleroderma Phenotype'' Pathway to Recapitulate the b TGF-Human Fibroblasts in Culture through the Autoantibodies to Fibrillin-1 Activate Normal

  2005cites this paper
• Autoantibodies in systemic sclerosis and fibrosing syndromes: clinical indications and relevance

  2004cites this paper
• Autoantibodies to a collagen‐specific molecular chaperone, heat‐shock protein 47, in systemic sclerosis

  2004cites this paper
• Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis.

  2004cites this paper
• Scleroderma--clinical and pathological advances.

  2004cites this paper
• IgG reactivity with a 100-kDa tissue and endothelial cell antigen identified as topoisomerase 1 distinguishes between limited and diffuse systemic sclerosis patients.

  2004cites this paper
• Impact of allergy on the ocular surface.

  2004cites this paper
• The tight skin mouse: an animal model of systemic sclerosis.

  2004cites this paper
• Systemic sclerosis: the susceptible host (genetics and environment).

  2003cites this paper
• Examination of the possible role of biologically relevant genes around FBN1 in systemic sclerosis in the Choctaw population.

  2003cites this paper